Stretching complements strengthening by maintaining tissue flexibility
The "gradual decline" group (approximately 40-50% of users) represents modal experience where benefits slowly regress toward pre-treatment baseline over 4-8 months, typically affecting users who completed shorter treatment courses (2-4 months), used lower concentrations or inconsistent application, possessed moderate to severe baseline skin damage requiring ongoing support, maintained adequate but not optimal complementary skincare, experienced significant lifestyle stressors affecting skin health including poor sleep or high stress, and faced genetic or age-related collagen production limitations
Abrogation of CC Chemokine Receptor 9 Ameliorates Collagen-Induced Arthritis of Mice
GHRP-6 + GHRH combinations are extensively represented in earlier research literature
Microdosing offers a potential middle ground, using lower doses to maintain some level of receptor activation, appetite regulation, and metabolic benefit without the full side effect burden of higher doses